multiple allergic reactions to medications containing PEG (for Comirnaty (Pfizer) or Spikevax (Moderna)) or polysorbate 80 (for Vaxzevria (AstraZeneca)).anaphylaxis or generalised allergic reaction (without anaphylaxis) to any component of the COVID-19 vaccine to be administered.Information specific to the paediatric and adult services provided by VicSIS and details on the VicSIS referral process are found below.Īdults with a history of any of the following conditions may be referred VicSIS prior to COVID-19 vaccination as they may be at higher risk of experiencing an adverse event following immunisation (AEFI):
Vaccination under supervision can be facilitated where deemed necessary. VicSIS clinicians provide comprehensive consultations and individualised advice, both pre- and post-vaccination either face-to-face or via telehealth appointments. It provides specialist vaccination services for adults and children (≥ 5 years of age) who have experienced an adverse event following immunisation (AEFI) with a COVID-19 vaccine, or for those who are identified as at-risk of experiencing an AEFI. The VicSIS team includes a broad range of vaccine experts, including infectious diseases specialists, immunologists, allergists, paediatricians and nurse practitioners. It was established to help support the COVID-19 vaccine rollout, initially in adults, but has recently been expanded to include paediatric sites.
The Victorian Specialist Immunisation Services (VicSIS) network is a collaboration between the Victorian Department of Health and SAEFVIC MCRI, Parkville, Melbourne.
0 kommentar(er)
